Clinical trial
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
NCT04130997
Study timeline
Study start (actual)2019-11-18Date precision: day
Registry last updated2026-09-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Multiple Sclerosis (RMS)unresolved
Interventions
UblituximabBIOLOGICAL
Sponsors & collaborators
TG Therapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04130997 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.